In particular, we explored the enhancing effect of CsA on IFNγ pre-licenced MSC capacity to suppress pathogenic T cell responses and prolong survival in an humanised mouse model of acute graft versus host disease (Fig. 5a). The gene discussed is IFNG; the disease is graft versus host disease.